Page 47 - 82_02
P. 47
A historical overview of protein kinase PKR… 123. Nozawa Y, Van Belzen N, Van der Made AC,
Dinjens WN, Bosman FT. Expression of
repeat family of proteins. Mol. Cell. Biol. 1994; nucleophosmin/B23 in normal and neoplastic
14:2331–2342. colorectal mucosa. J. Pathol. 1996; 178:48–52.
111. Jiang P, Wen J, Song H, Chen X, Sun Y, Huo 124. Pang Q, Christianson TA, Koretsky T, et al.
X, Zhang D. Characterization of porcine P58IPK gene Nucleophosmin interacts with and inhibits the
and its up-regulation after H1N1 or H3N2 influenza catalytic function of eukaryotic initiation factor 2
virus infection. J Clin Virol. 2013;58(1):120-6. kinase PKR. J. Biol. Chem. 2003 ; 278:41709–41717.
112. Gale M, Blakely CM, Darveau A, Romano PR, Korth 125. Lee K, Kunkeaw N, Jeon SH, et al. Precursor miR-
MJ, Katze MG. P52rIPK regulates the molecular 886, a novel noncoding RNA repressed in cancer,
cochaperone P58IPK to mediate control of the RNA- associates with PKR and modulates its activity. RNA
dependent protein kinase in response to cytoplasmic 2011;17, 1076–1089.
stress. Biochemistry 2002; 41:11878–11887.
126. Kunkeaw N, Jeon SH, Lee K, et al. Cell
113. Gilbert SJ, Meakin LB, Bonnet CS, et al. Deletion of death/proliferation roles for nc886, a non-coding
P58(IPK), the Cellular Inhibitor of the Protein RNA, in the protein kinase R pathway in
Kinases PKR and PERK, Causes Bone Changes and cholangiocarcinoma. Oncogene 2012; 32,3722–3731.
Joint Degeneration in Mice. Front Endocrinol
(Lausanne). 2014;5:174. 127. Lee HS, Lee K, Jang HJ, et al. Epigenetic silencing of
the non-coding RNA nc886 provokes oncogenes
114. Peters GA, Seachrist DD, Keri RA, Sen GC. The during human esophageal tumorogenesis Oncotarget.
double-stranded RNA-binding protein, PACT, is 2014;5(11):3472-81.
required for postnatal anterior pituitary proliferation.
Proc. Natl. Acad. Sci. U. S. A. 2009; 106, 10696– 128. Treppendahl MB, Qiu X, Søgaard A, et al. Allelic
10701. methylation levels of the noncoding VTRNA2-1
located on chromosome 5q31.1 predict outcome in
115. Clerzius G, Shaw E, Daher A, et al. The PKR AML. Blood. 2012;119(1):206-16.
activator, PACT, becomes a PKR inhibitor during
HIV-1 replication. Retrovirology 2013; 10, 96. 129. Blalock WL, Bavelloni A, Piazzi M, et al. Multiple
forms of PKR present in the nuclei of acute leukemia
116. Daniels SM, Gatignol A. The multiple functions of cells represent an active kinase that is responsive to
TRBP, at the hub of cell responses to viruses, stress, stress. Leukemia 2011; 25, 236–245.
and cancer. Microbiol. Mol. Biol. Rev. 2012; 76, 652–
666. 130. de la Cruz-Herrera CF, Campagna M, García MA, et
al. Activation of the double-stranded RNA-dependent
117. Sanghvi VR, Steel LF. The cellular TAR RNA protein kinase PKR by small ubiquitin-like modifier
binding protein, TRBP, promotes HIV-1 replication (SUMO). J Biol Chem. 2014;289(38):26357-67.
primarily by inhibiting the activation of double-
stranded RNA-dependent kinase PKR. J. Virol. 2011; 131. Marchal JA, Lopez GJ, Peran M, et al. The impact of
85, 12614–12621. PKR activation: from neurodegeneration to cancer.
FASEB J. 2014; 28(5):1965-74.
118. Singh M, Castillo D, Patel CV, Patel RC. Stress-
induced phosphorylation of PACT reduces its 132. Chong KL, Feng L, Schappert K, et al. Human p68
interaction with TRBP and leads to PKR activation. kinase exhibits growth suppression in yeast and
Biochemistry 2011; 50, 4550–4560. homology to the translational regulator GCN2. EMBO
J. 1992;11, 1553–1562.
119. Chan CT, Reeves RE, Geller R, et al. Discovery and
validation of small-molecule heat-shock protein 90 133. Meurs EF, Galabru J, Barber GN, Katze MG,
inhibitors through multimodality molecular imaging in Hovanessian AG. Tumor suppressor function of the
living subjects. Proc. Natl. Acad. Sci. U. S. A. 2012; interferon-induced double-stranded RNA-activated
109, 2476–2485. protein kinase. Proc. Natl. Acad. Sci. U. S. A.1993;
90, 232–236.
120. Zhao M, Tang D, Lechpammer S, et al.
Doublestranded RNA-dependent protein kinase (pkr) 134. Koromilas AE, Roy S, Barber GN, Katze MG,
is essential for thermotolerance, accumulation of Sonenberg N. Malignant transformation by a mutantof
HSP70, and stabilization of ARE-containing HSP70 the IFN-inducible dsRNA-dependent protein kinase.
mRNA during stress. J. Biol. Chem.2002; 277, Science1992; 257, 1685–1689.
44539–44547.
135. Barber GN, Jagus R, Meurs EF, Hovanessian AG,
121. Pang Q, Keeble W, Christianson TA, Faulkner GR, Katze MG. Molecular mechanisms responsible for
Bagby GC. FANCC interacts with Hsp70 to protect malignant transformation by regulatory and catalytic
hematopoietic cells from IFN-gamma/TNF-alpha- domain variants of the interferon-induced enzyme
mediated cytotoxicity. EMBO J. 2001; 20, 4478– RNA-dependent protein kinase. J. Biol. Chem 1995;
4489. 270, 17423–17428.
122. Itahana K, Bhat P, Jin A, et al. Tumor suppresso r 136. Mounir Z, Krishnamoorthy JL, Robertson GP, et al.
ARF degrades B23, a nucleolar protein involved in Tumor suppression by PTEN requires the activation of
ribosome biogenesis and cell proliferation. Mol. Cell
2003; 12:1151– 1164. 165
@Real Academia Nacional de Farmacia. Spain
